Sarah Boylan Cavanaugh

Sarah Boylan Cavanaugh has held various roles in the field of corporate communications and investor relations. Sarah started their career at the American Cancer Society in 1996, where they worked in several positions and eventually became the Mid-South Division Communications and Marketing Director. In this role, they were responsible for developing and implementing annual communications and marketing plans across six states. Sarah then joined Fallon Community Health Plan in 2001 as the Director of Corporate Communications, leading a team that served over 20 internal clients. In 2005, they moved to Point Therapeutics as the Director of Corporate Communications and Investor Relations. Sarah later joined MacDougall Biomedical Communications in 2007 as the Vice President. Finally, in 2012, they joined Celldex Therapeutics as the Vice President of Investor Relations & Corporate Communications, and eventually became the Senior Vice President of Corporate Affairs and Administration in 2017.

Sarah Boylan Cavanaugh attended the University of New Hampshire from 1992 to 1995. No specific degree or field of study was mentioned.